Key Market Segments:
By Product
-
Instruments
-
Consumables
-
Reagents & Kits
-
Animal Models
-
By Test Type
-
Acute
-
Sub-Acute
-
Sub-Chronic
-
Chronic Test Type
By Testing Facility
-
Outsourced Testing Facility
-
In-House Testing Facility
By Toxicity Endpoint
-
Immunotoxicity
-
Systemic Toxicity
-
Carcinogenicity
-
Genotoxicity
-
Developmental & Reproductive Toxicity (DART)
-
Others
By End User
-
Academic and Research Institutes
-
Pharmaceutical & Biotechnology Companies
-
Contract Research Organizations
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Turkey
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g., Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market is expected to grow from USD 8.66 billion in 2025 to USD 25.90 billion by 2035, registering a CAGR of 11.58% during 2026–2035.
Market growth is driven by increasing pharmaceutical and biotechnology drug development, rising demand for preclinical safety testing, expanding CRO services, and stricter regulatory requirements for drug approval.
The consumables segment dominated the market in 2025, accounting for 61.48% share, due to continuous use of reagents, kits, and animal models in toxicology studies.
North America holds the largest market share (about 41.26% in 2025) due to strong pharmaceutical R&D infrastructure and strict regulatory frameworks.
Pharmaceutical and biotechnology companies represent the largest end-user segment, driven by extensive drug development pipelines and regulatory safety testing requirements.